A Randomized, Double-Blind, Multicenter, Placebo- and Active Comparator-Controlled Study to Evaluate Efficacy and Safety of MR308 in the Treatment of Acute Pain After Third Molar Tooth Extraction (STARDOM1).
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 20 Feb 2018
At a glance
- Drugs Celecoxib/tramadol (Primary) ; Tramadol
- Indications Pain
- Focus Registrational; Therapeutic Use
- Acronyms STARDOM1
- Sponsors Mundipharma Research
- 17 Jan 2018 This trial has been completed in Germany (End date: 2018-01-04) according to European Clinical Trials Database record.
- 18 Dec 2017 Status changed from recruiting to active, no longer recruiting.
- 02 Jan 2017 Status changed from not yet recruiting to recruiting.